share_log

Oppenheimer Reiterates Outperform on Kala Bio, Maintains $15 Price Target

Moomoo 24/7 ·  Apr 1 09:23

Oppenheimer analyst Francois Brisebois reiterates Kala Bio (NASDAQ:KALA) with a Outperform and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment